-
-
-
-
-
-
-
Benitec BioPharma (BNTC) Reiterated at Market Outperform by Citizens on Q3 Update
-
-
-
-
-
-
-
TD Cowen on Benitec BioPharma (BNTC): 'Updated Interim Ph1/2 '301 OPMD Dysphagia Data Impresses'
-
-
-
-
-
-
-
Benitec Biopharma to restate quarterly financial statements
-
-
-
-
-
-
-
Benitec BioPharma (BNTC) PT Raised to $20 at Citizens JMP
-
-
-
-
-
-
-
Benitec Biopharma (BNTC) Announces Acceptance of Late- Breaking Oral Abstract for the BB-301 Phase 1b/2a Clinical Study at the Muscular Dystrophy Association Clinical and Scientific Conference
-
-
-
-
-
-
-
Piper Sandler Reiterates Overweight Rating on Benitec BioPharma (BNTC)
-
-
-
-
-
-
479,088 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


